Pharmaceutical SAP ERP Deal

By  |  September 25, 2014
 | 

Giving itself a B2B shot in the arm boost, the DAWA pharmaceutical group has signed a deal for ERP software from SAP Africa.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    “By using SAP’s solutions, we are finally able to standardise our operating procedures and tightly integrate functionality in facets such as production planning, inventory control, payroll, sales and distribution” said Dr Jitendra Rishi, Technical Director, DAWA Limited.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    The move has slashed stock holding to five percent since April, according to a report in All Africa.


    Recommended

    Bessent Says Crypto Firms Are Sabotaging Best Chance for Rules

    Figure, blockchain

    Figure Tests Future of Trading With Blockchain Stock Launch

    AI, pharmaceuticals, drug discovery

    Pharma Rewires Drug Development With AI Operations

    Crypto Advocates Urge UK’s FCA to Narrow Regulatory Scope

    See More In: , , ,